2 Pharma Stocks to Buy Hand Over Fist This Month
Few pharmaceutical companies are more prominent than Pfizer (NYSE: PFE) and Bristol Myers Squibb (NYSE: BMY). However, their popularity relative to most of their peers hasn't helped them much in the past few years: Both drugmakers have substantially lagged the market. Pfizer and Bristol Myers have had their share of troubles, but there is plenty to like about both stocks, at least for investors with an investment horizon spanning five years or more. Read on to find out why both stocks are worth buying this month.
Source Fool.com
Pfizer Inc. Stock
€26.10
-0.190%
The stock is one of the favorites of our community with 31 Buy predictions and 4 Sell predictions.
As a result the target price of 41 € shows a very positive potential of 57.09% compared to the current price of 26.1 € for Pfizer Inc..
